Humana Performance dei guadagni passati

Il passato criteri di controllo 0/6

Gli utili di Humana sono diminuiti a un tasso medio annuo di -8%, mentre il settore Healthcare ha visto gli utili crescere a un tasso medio annuo di 20.5%. I ricavi sono cresciuti crescere a un tasso medio annuo di 6.7%. Il ritorno sul capitale proprio di Humana è 3.8% e ha margini netti di 1.2%.

Informazioni chiave

-8.0%

Tasso di crescita degli utili

-5.6%

Tasso di crescita dell'EPS

Healthcare Crescita del settore	8.1%
Tasso di crescita dei ricavi	6.7%
Rendimento del capitale proprio	3.8%
Margine netto	1.2%
Prossimo aggiornamento sui guadagni	06 Feb 2025

Aggiornamenti sulle prestazioni recenti

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Oct 31

Recent updates

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Oct 31

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Oct 27

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Jul 22

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Ripartizione dei ricavi e delle spese

Come Humana guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

OM:HUM Ricavi, spese e utili (SEK Millions )
Data	Ricavi	Guadagni	Spese G+A
30 Sep 24	10,014	124	1,176
30 Jun 24	9,746	110	1,167
31 Mar 24	9,621	146	1,177
31 Dec 23	9,649	176	1,200
30 Sep 23	9,685	228	1,211
30 Jun 23	9,660	250	1,176
31 Mar 23	9,491	232	1,122
31 Dec 22	9,203	210	1,082
30 Sep 22	8,869	183	1,037
30 Jun 22	8,530	203	988
31 Mar 22	8,347	242	963
31 Dec 21	8,186	276	926
30 Sep 21	8,000	293	891
30 Jun 21	7,896	279	896
31 Mar 21	7,825	272	902
31 Dec 20	7,771	262	913
30 Sep 20	7,750	230	86
30 Jun 20	7,739	249	104
31 Mar 20	7,670	197	113
31 Dec 19	7,446	188	89
30 Sep 19	7,247	222	-57
30 Jun 19	7,005	196	-34
31 Mar 19	6,774	245	-21
31 Dec 18	6,714	246	25
30 Sep 18	6,600	228	239
30 Jun 18	6,550	197	226
31 Mar 18	6,541	199	218
31 Dec 17	6,542	194	212
30 Sep 17	6,635	195	279
30 Jun 17	6,684	241	287
31 Mar 17	6,540	226	263
31 Dec 16	6,362	148	218
30 Sep 16	6,140	139	288
30 Jun 16	5,868	-11	230
31 Mar 16	5,713	-53	185
31 Dec 15	5,593	28	157
31 Dec 14	5,065	38	129
31 Dec 13	3,489	111	58

Guadagni di qualità: HUM ha un grande una tantum guadagno di SEK76.0M che ha avuto un impatto sui suoi ultimi 12 mesi di risultati finanziari pari a 30th September, 2024.

Margine di profitto in crescita: Gli attuali margini di profitto netti di HUM (1.2%) sono inferiori rispetto allo scorso anno (2.4%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di HUM sono diminuiti del 8% all'anno negli ultimi 5 anni.

Accelerare la crescita: HUM ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: HUM ha avuto una crescita negativa degli utili ( -45.6% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Healthcare ( 29.5% ).

Humana Performance dei guadagni passati

Il passato criteri di controllo 0/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Second quarter 2024 earnings released: EPS: kr0.02 (vs kr0.75 in 2Q 2023)

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Consensus EPS estimates increase by 14%

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 06, 2025

Humana AB Appoints Christoffer Herou as New CFO, Effective September 2, 2024

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Second quarter 2024 earnings released: EPS: kr0.02 (vs kr0.75 in 2Q 2023)

New minor risk - Shareholder dilution

Fredrik Larsson, CFO of the Humana Group, to Leave His Position

Price target increased by 7.1% to kr37.50

Humana AB (Publ) Announces CEO Changes

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 15%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Price target increased by 41% to kr23.50

New major risk - Share price stability

Investor sentiment improves as stock rises 42%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 16%

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS exceeds analyst expectations

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Price target decreased by 23% to kr45.67

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Investor sentiment deteriorates as stock falls 50%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Price target decreased by 7.8% to kr59.33

Price target decreased to kr60.33

Humana AB (Publ) Announces Management Changes

Price target decreased to kr64.33

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Is Humana (STO:HUM) Using Too Much Debt?

Humana AB Announces Nomination Committee for 2023 AGM

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

Price target decreased to kr79.00

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr81.50

Full year 2021 earnings: Revenues in line with analyst expectations

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock